Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Breaking & Recent News Twist Bioscience Corporation TWST

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throu...


Recent & Breaking News (NDAQ:TWST)

Twist Bioscience to Present at JSNN NanoImpacts 2022

Business Wire 3 hours ago

The Australian Research Council Centre of Excellence in Synthetic Biology and Twist Bioscience Partner to Foster and Accelerate Synthetic Biology Research in Australia

Business Wire September 20, 2022

Twist Bioscience to Present at Baird 2022 Global Healthcare Conference

Business Wire September 6, 2022

Twist Bioscience Reports Fiscal Third Quarter 2022 Financial Results

Business Wire August 5, 2022

Twist Bioscience to Present at Flash Memory Summit

Business Wire August 3, 2022

Twist Bioscience Highlights White Paper Sizing Future DNA Data Storage Market

Business Wire August 2, 2022

Twist Bioscience and Biotia Receive Expanded Emergency Use Authorization to Report Genetic Variants of SARS-CoV-2

Business Wire August 2, 2022

Twist Bioscience to Present at UBS Genomics 2.0 and Medtech Innovations Summit

Business Wire August 1, 2022

Twist Bioscience to Report Fiscal 2022 Third Quarter Financial Results on Friday, August 5, 2022

Business Wire July 18, 2022

Twist Bioscience Launches Monkeypox Virus Synthetic DNA Controls

Business Wire July 14, 2022

DNAnexus and Twist Bioscience Collaborate to Provide Data Analysis Software for NGS Workflow

Business Wire July 13, 2022

Twist Bioscience Opens New Twist Boston Location to Expand Antibody Discovery Capacity

Business Wire July 6, 2022

Twist Bioscience and Ildong Pharmaceutical Enter into a Collaboration to Enhance Antibody Discovery for Applications in Immuno-oncology

Business Wire June 30, 2022

Twist Bioscience to Present at Fujifilm's 12th Annual Global IT Executive Summit

Business Wire June 16, 2022

Twist Bioscience Launches Rapid Turnaround, Customizable Panels to Advance R&D in Minimal Residual Disease (MRD) Detection in Cancer Screening

Business Wire June 7, 2022

Twist Bioscience to Present at Upcoming Investor Conferences

Business Wire June 2, 2022

Twist Bioscience Launches Human Methylome Panel to Enable Detection of Methylation Fractions in a Diverse Range of Applications

Business Wire May 31, 2022

Twist Bioscience to Present at the 2022 UBS Global Healthcare Conference

Business Wire May 18, 2022

Interpace Biosciences Announces First Quarter 2022 Financial and Business Results

GlobeNewswire May 16, 2022

Twist Bioscience Announces Participation in SRC Panel at the 2022 MRS Spring Meeting and Exhibit

Business Wire May 10, 2022